Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.


TSXV:BTI.H - Post by User

Post by Sinbobon Jul 21, 2012 10:59am
356 Views
Post# 20138097

The way I understand it....

The way I understand it....

there may not be much news until mid August to early Sept. The TTU info could be anywhere in that time. Shire has until Sept. 15th for official response. Several collaboration agreement discussions are ongoing. Abbott may also respond during Sept. ...or earlier. If I were a pharma pursuing outstanding, short term opportunity I would not hesitate...for he who hesitates is lost.

Of course all above conjecture is just that, but from a reliable source.... and it is all public knowledge at this time. Call IR for confirmation. What we don't know is how any pharma may act and anything could happen at any time. That is the wild card. So, anyone trading or taking a chance here may be sucker punched if some very positive news was suddenly annonced. At the very least, there is an awful lot of news coming before end Sept.

Bullboard Posts